Aditya Birla Sun Life Nifty Healthcare ETF
Direct · Growth ₹16.95
18 Aug 2026
NAV
21.9%
3Y CAGR
21.3%
Weighted CAGR
?
Weighted Mean CAGR
Gives more importance to longer time periods (10Y, 20Y) than shorter ones (1Y, 3Y). This balances out recent outperformance and gives a more realistic picture of what long-term returns might look like.
Gives more importance to longer time periods (10Y, 20Y) than shorter ones (1Y, 3Y). This balances out recent outperformance and gives a more realistic picture of what long-term returns might look like.
6.45
Sharpe
-18.3%
Max Drawdown
?
Max Drawdown
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
0.19%
TER
If you invested ₹1,00,000 every month via SIP, here's how this fund has historically performed across different time horizons.
| Duration | Invested | Median Value | XIRR | Min XIRR | Max XIRR |
|---|---|---|---|---|---|
| 1 Year | ₹12.00 L | ₹12.63 L | 20.3% | -14.9% | 77.6% |
| 3 Years | ₹36.00 L | ₹48.81 L | 22.2% | 9.3% | 36.8% |
SIP returns vs benchmark & category
Annualised SIP return (XIRR) over each rolling horizon — like-for-like, not lump-sum.
| Duration | Fund SIP XIRR | Category avg |
|---|---|---|
| 1 Year | 20.3% | 16.2% |
| 3 Years | 22.2% | 11.5% |
| Duration | Mean | Median | Min | Max | Sharpe | Sortino | % Positive | Cat. Mean | Cat. Median |
|---|---|---|---|---|---|---|---|---|---|
| 1 Year | 19.5% | 14.6% | -12.2% | 63.6% | 0.65 | 2.56 | 84% | — | — |
| 3 Years | 21.9% | 22.4% | 15.6% | 27.3% | 6.45 | — | 100% | — | — |
-18.3%
Max Drawdown
6 mo
Drawdown Duration
13 mo
Recovery Time
-5.0%
Avg Drawdown
Calmar Ratio by Duration
1.07
1Y
1.20
3Y
19
Total Holdings
76.8%
Top 10 Weight
2
Sectors
| # | Stock | % of NAV |
|---|---|---|
| 1 | Sun Pharmaceutical Industries Limited | 18.13% |
| 2 | Apollo Hospitals Enterprise Limited | 8.21% |
| 3 | Max Healthcare Institute Limited | 7.73% |
| 4 | Divi's Laboratories Limited | 7.69% |
| 5 | Dr. Reddys Laboratories Limited | 7.60% |
| 6 | Cipla Limited | 7.58% |
| 7 | Laurus Labs Limited | 5.43% |
| 8 | Lupin Limited | 5.40% |
| 9 | Fortis Healthcare Limited | 4.58% |
| 10 | Torrent Pharmaceuticals Limited | 4.46% |